Covestor’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
Other funds holding CTKB
Covestor's CTKB Position: Q3 2026 in Review
Covestor reduced its Cytek Biosciences (CTKB) stake by 38% in Q3 2026, selling an estimated $128 and leaving 44 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2448.
Covestor first reported a position in CTKB in Q1 2022 and has held it in 19 quarters since. 109 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.
- Covestor held 44 shares of Cytek Biosciences worth $0 as of Q3 2026.
- Covestor sold 27 Cytek Biosciences shares in Q3 2026, an estimated $128.
- Cytek Biosciences made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2448 holding.
- Covestor first reported a position in Cytek Biosciences in Q1 2022 and has held it in 19 quarters since.
- 109 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.